Walleye Capital’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Walleye Capital’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,900	Closed	-$223K	–	1943
2019 Q4	$223K	Buy	4,900 +3,700	+308%	+$175K	0.01%	1054
2019 Q3	$55K	Sell	1,200 -3,900	-76%	-$219K	﹤0.01%	1585
2019 Q2	$299K	Sell	5,100 -4,800	-48%	-$248K	0.03%	736
2019 Q1	$444K	Buy	+9,900	New	+$454K	0.07%	429

Walleye Capital's ARNA Position: Q1 2022 in Review

Walleye Capital sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 24,197 shares — an estimated $2.25M sold.

Walleye Capital first reported a position in ARNA in Q1 2019 and held it in 2 quarters. The position peaked at $2.25M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Walleye Capital reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Walleye Capital sold 24,197 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $2.25M.
Walleye Capital first reported a position in Arena Pharmaceuticals Inc in Q1 2019 and held it in 2 quarters.
Walleye Capital's Arena Pharmaceuticals Inc position peaked at $2.25M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Walleye Capital's 13F filing for Q1 2022, filed 16 May 2022.